Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc/LAT1 complex

Molecular Genetics and Metabolism

Volumn 86, Issue SUPPL., 2005, Pages 119-123

  Møller, Lisbeth Birk ^a   Paulsen, Marianne ^a   Koch, Richard ^b   Moats, Rex ^c   Guldberg, Per ^a   Güttler, Flemming ^a  

^a JOHN F KENNEDY INSTITUTE   (Denmark)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

4F2hc; Blood brain barrier; Genotype; LAT1; Phenotype; Phenylalanine

Indexed keywords

AMINO ACID TRANSPORTER; CD98 ANTIGEN; PHENYLALANINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID BRAIN LEVEL; ARTICLE; BRAIN; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE; GENE SEQUENCE; GENE STRUCTURE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPOTHESIS; NUCLEOTIDE SEQUENCE; PHENYLKETONURIA; PREDICTION; PRIORITY JOURNAL;

EID: 28844460669     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.07.031     Document Type: Article

References (23)

1. F. Güttler, C. Azen, P. Guldberg, A. Romstad, W.B. Hanley, H.L. Levy, R. Matalon, B.M. Rouse, F. Trefz, F. de la Cruz, and R. Koch Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the maternal phenylketonuria collaborative study Pediatrics 104 1999 258 262
2. P. Guldberg, F. Rey, J. Zschocke, V. Romano, B. Francois, L. Michiels, K. Ullrich, G.F. Hoffmann, P. Burgard, H. Schmidt, C. Meli, E. Riva, I. Dianzani, A. Ponzone, J. Rey, and F. Güttler A european multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype Am. J. Hum. Genet. 63 1998 71 79
3. F. Güttler, and E. Wamberg Fasting serum phenylalanine in untreated institionalized patients with phenylketonuria J. Ment. Def. Res. 21 1977 55 61
4. H.C. Lou, P.B. Toft, J. Andresen, I. Mikkelsen, B. Olsen, P. Guldberg, and F. Güttler Unchanged MRI of myelin in adolescents with PKU supplied with non-phe essential amino acids after dietary relaxation Acta Pediatr. 83 1994 1312 1314
5. H.E. Moller, J. Weglage, U. Bick, D. Wiedermann, R. Feldmann, and K. Ullrich Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria Pediatrics 112 2003 1580 1583
6. R.A. Moats, R. Koch, K. Moseley, P. Guldberg, F. Güttler, R.G. Boles, and M.D. Nelson Jr. Brain phenylalanine concentration in the management of adults with phenylketonuria J. Inherit. Metab. Dis. 23 2000 7 14
7. R. Koch, R. Moats, F. Güttler, P. Guldberg, and M. Nelson Jr. Blood-brain phenylalanine relationships in persons with phenylketonuria Pediatrics 106 2000 1093 1096
8. Y. Kanai, H. Segawa, K. Miyamoto, H. Uchino, E. Takeda, and H. Endou Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) J. Biol. Chem. 273 1998 23629 23632
9. R.J. Boado, J.Y. Li, M. Nagaya, C. Zhang, and W.M. Pardridge Selective expression of the large neutral amino acid transporter at the blood-brain barrier Proc. Natl. Acad. Sci. USA 96 1999 12079 12084
10. R. Koch, B. Burton, G. Hoganson, R. Peterson, W. Rhead, B. Rouse, R. Scott, J. Wolff, A.M. Stern, F. Güttler, M. Nelson, F. de la Cruz, J. Coldwell, R. Erbe, M.T. Geraghty, C. Shear, J. Thomas, and C. Azen Phenylketonuria in adulthood: a collaborative study J. Inherit. Metab. Dis. 25 2002 333 346
11. J. Grimberg, S. Nawoschik, L. Belluscio, R. McKee, A. Turck, and A. Eisenberg A simple and efficient non-organic procedure for the isolation of genomic DNA from blood Nucleic Acids Res. 17 1989 8390
12. S.J. Ramus, S.M. Forrest, D.D. Pitt, and R.G. Cotton Genotype and intellectual phenotype in untreated phenylketonuria patients Pediatr. Res. 45 1999 474 481
13. J. Pietz, R. Kreis, A. Rupp, E. Mayatepek, D. Rating, C. Boesch, and H.J. Bremer Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria J. Clin. Invest. 103 1999 1169 1178
14. R. Koch, K.D. Moseley, S. Yano, M. Nelson Jr., and R.A. Moats Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment Mol. Genet. Metab. 79 2003 110 113
15. H. Segawa, Y. Fukasawa, K. Miyamoto, E. Takeda, H. Endou, and Y. Kanai Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity J. Biol. Chem. 274 1999 19745 19751
16. E. Babu, Y. Kanai, A. Chairoungdua, K. Kim do, Y. Iribe, S. Tangtrongsup, P. Jutabha, Y. Li, N. Ahmed, S. Sakamoto, N. Anzai, S. Nagamori, and H. Endou Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters J. Biol. Chem. 278 2003 43838 43845
17. S. Bodoy, L. Martin, A. Zorzano, M. Palacin, R. Estevez, and J. Bertran Identification of LAT4, a novel amino acid transporter with system L activity J. Biol. Chem. 280 2005 12002 12011
18. W.M. Pardridge Brain metabolism: a perspective from the blood-brain barrier Physiol. Rev. 63 1983 1481 1535
19. M.B. Shapiro, and P. Senapathy RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression Nucleic Acids Res. 15 1987 7155 7174
20. M. Ikeda, M. Levitt, and S. Udenfriend Phenylalanine as substrate and inhibitor of tyrosine hydroxylase Arch. Biochem. Biophys. 120 1967 420 427
21. P. Ribeiro, D. Pigeon, and S. Kaufman The hydroxylation of phenylalanine and tyrosine by tyrosine hydroxylase from cultured pheochromocytoma cells J. Biol. Chem. 266 1991 16207 16211
22. M.H. Fukami, J. Haavik, and T. Flatmark Phenylalanine as substrate for tyrosine hydroxylase in bovine adrenal chromaffin cells Biochem. J. 268 1990 525 528
23. C. Vadasz, I. Sziraki, L.R. Murthy, I. Vadasz, A.F. Badalament, G. Kobor, and A. Lajtha Genetic determination of mesencephalic tyrosine hydroxylase activity in the mouse J. Neurogenet. 4 1987 241 252